Achieve Life Sciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Achieve Life Sciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Achieve Life Sciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Achieve Life Sciences Inc. is ACHV:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Achieve Life Sciences Inc. has its primary listing on NASDAQ. You can trade Achieve Life Sciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Achieve Life Sciences Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Achieve Life Sciences Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Achieve Life Sciences Inc..